Search filters

Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children.

Image Image of a generic work. The text above it indicates that there is no free image of the work available, and that if you own one, you can click on the placeholder link to upload it.
Description scientific article published on 20 August 2016
Author/s

author: Alexandre Belot  Frédéric Rieux-Laucat  Mathieu Rodero  Eric Jeziorski  Thierry Walzer  Brigitte Bader-Meunier  Laureline Berteloot  Despina Moshous  Darragh Duffy  Yanick J. Crow 

Publication date August 20, 2016
Language English
Country of origin
Wikipedia link
Copyright status
Missing/wrong data? Edit Wikidata item